Harbour BioMed
和铂医药
elsewhere's corpus does not cover Harbour BioMed as a subject. The only mention in the retrieved material is a passing name-drop in a 2023 BlueRun Ventures piece about BioMap, which notes that BioMap had established partnerships with "晶准生物、和铂医药、领星生物、普瑞基准、新景智源等多家前沿企业" — 和铂医药 being Harbour BioMed's Chinese name . No entity card, founding date, strategy, or team details about Harbour BioMed itself appear in the bundle.
AI-generated — may contain errors, please verify.
Harbour BioMedCompany
和铂医药
渲染中…
Mentioned in 3 articles
Coverage
Deep Dive: China's "DeepSeek Moment" in Biotech | FreeS Fund Report
A Watershed Year for China's Innovative Drug Industry
$1 Billion! BioMap and Sanofi Partner to Develop AI Drug Discovery Models Based on Large Foundation Models | BlueRun Ventures Headlines
The First Commercial Partnership Based on Large Language Models in the Life Sciences Sector
The Hammer and the Dance: Where Healthcare Investment Goes Next Under COVID-19 | FreeS Fund
The unexpected arrival of COVID-19 turned out to be a shot in the arm for the healthcare industry.
